• Blog Post
  • Webinar

Webinar: Medication-assisted Treatment: Trends and Outcomes

Dec 20th, 2022

For consumers living with opioid use disorder (OUD), medication-assisted treatment (MAT) has become the gold standard of treatment. In a new webinar, Genoa Healthcare Director of Operations Megan Garrity, PharmD, and Pharmacist Ryan Grant, PharmD, share how MAT programs can impact patients and clinics.

Frequently Asked Questions:

  • For more information about Narcan and Sublocade, please reach out to your Genoa Healthcare pharmacy team. You can also reach out directly to Indivior for more information on Sublocade by calling their Medical Information Line at 1-877-782-6966.
  • For questions on SAMSHA, please click here.

Studies referred to in this webinar:

Let’s talk

Reliable, full-service pharmacy care

Interested in learning more about how Medication-assisted treatment can help support your consumers? Genoa can help. Contact us today and we’ll be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Recent Posts

  • Blog Post
Partnering with ACT teams to make an even bigger impact

Genoa Healthcare® pharmacist Julie R. has seen firsthand the impact that severe and persistent mental illness can have on a person. For one of her consumers living with schizophrenia, the...

  • Blog Post
  • Webinar
For consumers living with Tardive Dyskinesia, Genoa Healthcare’s Clinical Assistance Program offers personalized support

Tardive Dyskinesia – a neurological disorder linked to prolonged use of antipsychotic medications – impacts over 600,000 individuals each year. Did you know that 50% of consumers taking TD medication...

  • Blog Post
A foundation to build on: 3 ways an engaged pharmacy partner helps you deliver whole-person health

A recent survey found that nearly 60% of behavioral health, primary care and complex care providers reported that their organization currently offered or had plans to begin offering integrated care...

  • Clinical Insights
  • Webinar
Understanding Tardive Dyskinesia: What you need to know

Tardive Dyskinesia (TD) – a neurological disorder associated with prolonged use of antipsychotic medications – affects over 600,000 people annually. Wondering what this means for the people you serve? Genoa...